Advertisement

Medtech titan Boston Scientific launches its newly acquired fiXate tissue band, a semi-automatic suturing system for spinal cord stimulator leads and pain pump catheters.

M&A illustration

Medical device maker Boston Scientific (NYSE:BSX) acquired the fiXate tissue band from Anulex Technologies, launching the suturing system right away.

The fiXate device is a semi-automatic suturing system designed to secure spinal cord stimulator leads and pain pump catheters, touting deployment in under 1 minute in bench testing, according to a press release.

Advertisement
Advertisement